IntellipharmaCeutics Inc. has announced its annual earnings for the first Quarter of FY-2015. The results shows the following: Revenues down 76.6%, Operating Loss down 136% and EPS Downs 144%. View the full earnings release here.
IntellipharmaCeutics Lower Earnings $IPCI $XHS Read More »
Ichor Medical Systems, Inc., has announced a joint collaboration with Johnson & Johnson to generate develop and Commercialize Immunotherapies Delivered with TriGrid Electroporation Device for Chronic Hepatitis B. View the full release here.
JNJ Development in Hep B Vaccine $JNJ $XHS Read More »
Cipher Pharmaceuticals Inc. has announced to acquire a US privately held specialty dermatology company, Innocutis Holdings LLC., for 45.5 Million US Dollars cash. The major goal is to enter the US Market and step forward in Dermatology Business. View the full release here.
Cipher Acquiring Innocutis $CPHR $XHS Read More »
AngioDynamics, a leading provider of medical devices for vascular access, surgery, peripheral vascular disease and oncology, has announced its third quarter results for FY-2015. The results shows the following, Net sales of $86.6 million decreased 2% Y/Y, GAAP Net Loss per share is -$0.12 from -$0.13 Y/Y whereas EBITDS per share has improved at -$0.04 from $-0.39 Y/Y.
AngioDynamics Earnings Down $ANGO $XHS Read More »
FDA has granted Adamas Pharmaceuticals, Inc. Orphan drug staus to the firm’s ADS-5102 for the treatment of Levodopa-induced Dyskinesia associated with Parkinson’s disease. View the full release here.
Adamas Orphaned for Parkinson Cure $ADMS $XHS Read More »
